Your session is about to expire
← Back to Search
Nasal Flu Vaccine for COPD
Study Summary
This trial will study how people with and without COPD respond to the influenza vaccine when given through the nose.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was hospitalized due to COVID-19.If you are in the healthy control group, your blood pressure should be between 90/55 and 160/90.I do not have any nasal symptoms according to a questionnaire.You have had severe allergic reactions to certain things in the past.I have not used any chronic immunosuppression medication in the last 30 days.I am willing and able to follow the study's procedures for COPD.I have not had a respiratory infection in the last 4 weeks.I am experiencing wheezing at the time of my visit.You have smoked cigarettes or used e-cigarettes in the last six months.I often have easy bruising or my gums bleed.I have had nosebleeds, nasal surgery, or unusual nose shapes.I have been diagnosed with asthma.I have used nasal sprays for allergies within the last month.I have been diagnosed with COPD, confirmed by a specific breathing test.I am on regular antibiotics to prevent infections.I have not had the COVID-19 vaccine within 14 days before or plan to until 14 days after the study.I am over 40 years old and considered healthy.I have had Guillain-Barre syndrome in the past.You have a positive result for HIV in your blood test.I take prednisone pills every day.You cannot stay away from people with weakened immune systems for 3 weeks after getting the LAIV vaccine.I use oxygen therapy more than just at night.You have a long-term illness that weakens your immune system.My blood pressure is between 90/55 and 160/90 mm Hg.I was diagnosed with or suspected to have had the flu in the last 18 months.I have received the nasal spray flu vaccine this or last flu season.I am over 40 years old and have COPD.I have COPD and no nasal symptoms according to a questionnaire.I am currently taking a blood thinner that is not just aspirin.People with COPD must have oxygen levels above 94% while at rest.If you are in the healthy control group, your oxygen level while resting should be more than 94 percent.Your blood test shows low levels of white blood cells, neutrophils, or lymphocytes.I haven't had a severe COPD flare-up in the last four weeks.People in the healthy control group must have normal lung function when tested with spirometry.
- Group 1: COPD Frequent Exacerbators
- Group 2: COPD Infrequent Exacerbators
- Group 3: Healthy Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still available for the current trial?
"At this time, the study is not accepting candidates. Data hosted on clinicaltrials.gov reveals that it was initially posted October 1st 2022 and last updated August 9th 2022. Presently, 339 studies are actively recruiting participants with lung ailments while 6 trials for LAIV have opened their doors to applicants."
Has the scientific community conducted any other investigations involving LAIV?
"Presently, there are 6 studies for LAIV in progress. None of these trials have reached phase 3 yet and the majority take place at Stanford University California with other sites scattered across America."
What is the absolute most that this exploration can include in terms of individuals?
"Recruitment for this clinical trial has been suspended. It was initially posted on October 1st 2022 and the last edits were made on August 9th 2022. If you wish to pursue alternative studies, there are currently 339 trials recruiting participants with lung diseases such as obstructive pulmonary disease and 6 trails focusing on LAIV actively seeking patients."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger